Hematopoietic progenitor cells (HPC) are stored in cryopreservation bags that are resistant to liquid nitrogen. Since Cryocyte bags of Baxter (B-bags) are no longer available, an alternative bag was sought. Also, the influence of freezing volume was studied. Miltenyi Biotec (MB)- and MacoPharma (MP)-bags passed the integrity tests without failure. Comparing MB- and MP-bags with B-bags, no difference in WBC recovery or viability was found when using a WBC-enriched product as a "dummy" HPC product. Further, a freezing volume of 30 mL resulted in better WBC recovery and viability than 60 mL. Additonal studies using real HPC might be necessary.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.transci.2014.12.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cryopreservation Protocols and the Associated Ultrastructural Changes in Dormant Buds of .
Plants (Basel)
December 2024
College of Horticulture, Jilin Agricultural University, Changchun 130118, China.
There is an urgent need for the cryopreservation of dormant buds to conserve the genetic resources of woody plants, particularly fruit trees, as this method is less time-consuming and relatively inexpensive. In the present study, three different cryopreservation protocols were tested on dormant buds from three varieties of Rupr. The explants were collected between November 2017 and March 2018.
View Article and Find Full Text PDFPhysical vitrification and nanowarming at human organ scale to enable cryopreservation.
bioRxiv
November 2024
Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA.
Organ banking by vitrification could revolutionize transplant medicine. However, vitrification and rewarming have never been demonstrated at the human organ scale. Using modeling and experimentation, we tested the ability to vitrify and rewarm 0.
View Article and Find Full Text PDFCryopreservation of mesenchymal stem/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT/BEST collaborative study.
Cytotherapy
December 2024
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA; Molecular and Cellular Therapeutics, University of Minnesota, Saint Paul, Minnesota, USA.
Article Synopsis
- A study was conducted to compare a new DMSO-free cryoprotectant solution with traditional DMSO solutions for freezing mesenchymal stem/stromal cells (MSCs) to prevent cell toxicity and ensure safe clinical use.
- The new solution, made of sucrose, glycerol, and isoleucine, was tested against 5-10% DMSO solutions prepared by seven different centers, focusing on the viability and recovery of MSCs after thawing.
- Results showed that while the average viability of MSCs decreased with both solutions post-cryopreservation, the DMSO-free solution displayed a more significant reduction in cell viability compared to the traditional DMSO solutions, highlighting its potential benefits for
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.
Blood Transfus
May 2024
Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.
Background: Chimeric antigen receptor (CAR) T-cell therapy is increasingly used in patients affected by B-cell lymphoma and acute lymphoblastic leukemia. For logistical reasons, initial apheresis products may be cryopreserved for shipment to manufacturing centers. Due to the characteristics of these patients, cells are often collected in large volumes, meaning more bags must be cryopreserved.
View Article and Find Full Text PDFLiquid Storage of Peripheral Blood Stem Cell Products: Effects of Time and Temperature on Product Quality.
Transplant Cell Ther
January 2024
Center for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
Unrelated donor peripheral blood stem cell (PBSC) products often require transport to distant locations, which may take up to 72 hours. Temperature is an important variable that can be controlled during PBSC storage or transport; therefore, we studied the impact of temperature on prolonged storage of clinical-grade, mobilized PBSC products. PBSC products were collected by apheresis from 3 granulocyte colony-stimulating factor-mobilized donors, split into 2 PVC blood bags of equal volume, and stored at room temperature (RT) (18°C to 25 ºC) or 4 °C (2°C to 8 ºC) for 96 hours.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!